创远信科(831961) - 2024 Q1 - 季度财报

Financial Performance - Operating revenue for Q1 2024 was ¥47,786,946.70, representing a decline of 28.52% year-over-year[9] - Net profit attributable to shareholders for Q1 2024 was a loss of ¥3,907,121.99, compared to a profit of ¥5,010,804.16 in the same period last year[9] - The net profit margin for Q1 2024 was -7.92%, reflecting the impact of reduced sales and increased R&D costs[11] - The company reported a net loss of CNY 4,517,009.60 for the period, compared to a net profit of CNY 4,729,123.39 in the same period last year, indicating a significant decline in profitability[53] - Total revenue for Q1 2024 was CNY 47,786,946.70, a decrease of 28.5% compared to CNY 66,854,928.19 in Q1 2023[52] - The company recorded a significant increase in other income, amounting to CNY 7,431,417.97, compared to CNY 5,016,867.64 in the previous year, contributing positively to the overall financial performance[55] - Basic and diluted earnings per share were both CNY -0.03, a decrease from CNY 0.04 in the same period last year, reflecting the overall decline in profitability[53] Cash Flow and Liquidity - The company's cash flow from operating activities showed a net outflow of ¥11,007,084.91, an improvement from a larger outflow of ¥14,095,348.58 in Q1 2023[9] - Cash and cash equivalents decreased to CNY 51,010,629.87 as of March 31, 2024, from CNY 84,724,562.94 as of December 31, 2023, showing liquidity challenges[49] - Total cash and cash equivalents at the end of Q1 2024 stood at 50,871,693.27, compared to 25,010,838.59 at the end of Q1 2023, reflecting a 103.4% increase year-over-year[62] - Cash inflow from operating activities totaled 43,805,256.36 in Q1 2024, down from 58,916,665.00 in Q1 2023, representing a decline of 25.7%[60] - The total cash flow from operating activities was impacted by a decrease in cash received from sales, which fell to 42,547,054.42 in Q1 2024 from 56,101,354.36 in Q1 2023, a decline of 24.2%[60] - The company experienced a negative cash flow from operating activities of CNY -11,007,084.91, compared to CNY -14,095,348.58 in the same period last year, showing an improvement in cash management[57] Assets and Liabilities - Total assets as of March 31, 2024, amounted to ¥1,158,871,510.56, a decrease of 1.71% compared to the end of 2023[9] - The company's total liabilities to assets ratio decreased to 34.30% from 35.34% year-over-year[9] - The company's total liabilities decreased from CNY 416,652,868.79 on December 31, 2023, to CNY 397,456,854.47 on March 31, 2024, indicating a reduction of about 4.3%[47] - The company's total equity decreased from CNY 762,358,183.91 to CNY 761,414,656.09, a slight reduction of approximately 0.1%[47] - The company's total current assets decreased from CNY 326,913,053.26 on December 31, 2023, to CNY 289,704,692.22 on March 31, 2024, representing a decline of approximately 11.4%[45] Research and Development - Research and development expenses increased by 39.18% to ¥27,966,570.56, primarily due to higher amortization of intangible assets and share-based payment expenses[11] - Research and development expenses increased to CNY 25,842,316.98, up 37.4% from CNY 18,800,608.05 in the previous year, reflecting a focus on innovation[55] - The company aims to expand its market presence and enhance product offerings through ongoing research and development initiatives[52] - The company plans to continue focusing on market expansion and product development to improve future performance, although specific strategies were not detailed in the report[53] Shareholder Information - The total number of ordinary shares is 142,840,508, with 73.82% being unrestricted shares held by controlling shareholders[16] - The largest shareholder, Chuangyuan Electronics, holds 38,762,632 shares, representing 27.14% of total shares[17] - The proportion of shares held by the top ten shareholders is 52.33%[18] - The company has a total of 7,107 ordinary shareholders[16] Stock Options and Incentives - The stock option incentive plan approved in September 2021 includes 96 core employees as participants[26] - The company approved the stock option incentive plan on October 11, 2021, granting 3,405,560 stock options to 109 incentive recipients[29] - On September 26, 2022, the company granted 1,076,000 stock options to 21 incentive recipients at an exercise price of 15.71 CNY per share[32] - As of April 21, 2023, the company canceled 2,935,357 stock options from the 2021 incentive plan due to employee departures and unmet performance conditions[33] - On October 27, 2023, the company canceled an additional 2,028,338 stock options from the 2021 incentive plan for similar reasons[34] - The company initiated the 2023 stock option incentive plan on October 25, 2023, with proposals for the first grant and core employee recognition[36] - The company granted 8,016,320 stock options to 150 incentive recipients as part of the 2023 stock option incentive plan, with the authorization date set for November 17, 2023[38] - A total of 7,926,020 stock options were actually granted to 146 incentive recipients, as disclosed on December 22, 2023[39] Legal and Compliance - The company has not engaged in any significant litigation or arbitration matters during the reporting period[22] - The company has timely fulfilled its obligations regarding related party transactions and external guarantees[22] - The company has no pledged or judicially frozen shares among its major shareholders[20] - The company has no new commitments during the reporting period, and all previously disclosed commitments have been fulfilled without violations[40]